USE OF C9ORF72 -MEDIATED GENES FOR DIAGNOSIS AND TREATMENT OF NEURONAL DISEASES Application WO-2023055657-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2023
Compositions for modulating C9ORF72 expression Grant US-11339393-B2 United States of America 24 May 2022
Compounds and methods for modulating C90RF72 Grant US-11260073-B2 United States of America 01 Mar 2022
Compositions for modulating expression of C9ORF72 antisense transcript Grant US-11193128-B2 United States of America 07 Dec 2021
Methods for modulating expression of C9ORF72 antisense transcript Grant US-11162096-B2 United States of America 02 Nov 2021
Compositions for modulating expression of C9ORF72 antisense transcript Grant US-10793855-B2 United States of America 06 Oct 2020
Compositions for modulating C9ORF72 expression Grant US-10443052-B2 United States of America 15 Oct 2019
Compositions for modulating expression of C9ORF72 antisense transcript Grant US-10407678-B2 United States of America 10 Sep 2019
Compositions for modulating C9ORF72 expression Grant US-10221414-B2 United States of America 05 Mar 2019
Compositions for modulating C9ORF72 expression Grant US-9605263-B2 United States of America 28 Mar 2017
METHODS FOR THE DIAGNOSIS OF AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL LOBAR… Application WO-2013041577-A1 World Intellectual Property Organisation (WIPO) 28 Mar 2013